Suppr超能文献

[神经胶质瘤的诊断与预后——分子诊断的当前前景]

[Diagnosis and prognosis of gliomas--current prospects of molecular diagnostics].

作者信息

Haapasalo Joonas, Hyartt Antti, Salmi Minja, Nordfors Kristiina, Lahtela Sirpa-Liisa, Kähkönen Marketta, Helén Pauli, Haapasalo Hannu

出版信息

Duodecim. 2014;130(9):893-901.

Abstract

Gliomas are tumors of the support cells of the brain and the most common of the primary brain tumors. Treatment of diffuse gliomas is based on surgical excision of the tumor and on radiotherapy and chemotherapy. The diagnosis is made in histopathological examination of the tumor, which today can be complemented with examinations involving molecular diagnostics. The most important new methods predicting the prognosis of glioma patients include demonstrations of the IDH mutation and the 1p/19q co-deletion. Profiling of gliomas may in the future allow tailoring of therapy in a patient-specific manner.

摘要

神经胶质瘤是脑支持细胞的肿瘤,也是最常见的原发性脑肿瘤。弥漫性神经胶质瘤的治疗基于肿瘤的手术切除以及放疗和化疗。诊断通过肿瘤的组织病理学检查做出,如今还可辅以分子诊断检查。预测神经胶质瘤患者预后的最重要的新方法包括IDH突变和1p/19q共缺失的检测。未来,神经胶质瘤的分析可能会实现针对患者的个性化治疗。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验